Procept Biorobotics: UnitedHealthcare Commercial Policy Effective December 1, 2022, Reiterates Aquablation as Unproven and Not Medically Necessary Due to Insufficient Evidence of Safety and/or Efficacy

UnitedHealthcare (UNH), the largest insurer in the country, recently released its prostate surgeries and interventions commercial medical policy effective December 1, 2022. The policy reiterates the insurer’s prior view that aquablation, which uses a high pressure saline solution to remove enlarged prostate tissue, is an unproven and not medically necessary procedure due to insufficient evidence […]

Tech/Media/Telecom Weekly: KIDS Act Passes House But Faces Tougher Reception in Senate; Smaller Satellite Services Vie for Market Share; New Rules on De Minimus Strengthen Enforcement; Class Action Against DRAM Makers Could Indicate Next Wave of Memory Litigation

The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the...

Jun 30, 2026 Read Now >

The European Antitrust Agenda: European Commission Defends ‘Call-In’ Powers; EU Executive’s IT Department Breaking Up with Contentious Broadcom Unit

Welcome to The European Antitrust Agenda, our weekly overview of European tech and competition law developments. Key stories we’re following this week include: • European Commission defends...

Jun 30, 2026 Read Now >

Somnigroup/Leggett & Platt: FTC Cleared Deal Without Contacting Major Industry Participants

The FTC cleared Somnigroup’s (SGI) $2.5 billion acquisition of Leggett & Platt (LEG) after just 30 days without contacting several major industry participants, including some that have concerns...

Jun 29, 2026 Read Now >

Procept Biorobotics: UnitedHealthcare Commercial Policy Effective December 1, 2022, Reiterates Aquablation as Unproven and Not Medically Necessary Due to Insufficient Evidence of Safety and/or Efficacy

RELATED ARTICLES | Corporate investigations

Tech/Media/Telecom Weekly: KIDS Act Passes House But Faces Tougher Reception in Senate; Smaller Satellite Services Vie for Market Share; New Rules on De Minimus Strengthen Enforcement; Class Action Against DRAM Makers Could Indicate Next Wave of Memory Litigation

The European Antitrust Agenda: European Commission Defends ‘Call-In’ Powers; EU Executive’s IT Department Breaking Up with Contentious Broadcom Unit

Somnigroup/Leggett & Platt: FTC Cleared Deal Without Contacting Major Industry Participants

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.